Home > Insider Trading > Filing (0000899243-21-004240)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Perkinelmer Inc	PKI	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1665985	R Daniel Tereau	940 Winter Street Waltham MA 02451	Please See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-01	2,951	$0.00	10,378	No	4	A	Direct
Common Stock	Disposition	2021-02-01	902	$147.07	9,476	No	4	F	Direct
Common Stock	Disposition	2021-02-01	405	$147.07	9,071	No	4	F	Direct
Common Stock	Acquisiton	2021-02-01	2,047	$81.29	11,118	No	4	M	Direct
Common Stock	Disposition	2021-02-01	2,047	$147.07	9,071	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Disposition	2021-02-01	2,047	$0.00	2,047	$81.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-01-30	No	4	M	Direct

Footnotes

Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on January 30, 2018.
These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on January 30, 2018, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement.
These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on January 30, 2018, as required by the Reporting Person's Restricted Stock Agreement.
The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Tereau on November 12, 2020.
This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted.